The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
This case study and associated publications (Naughton et al., 2017, 2016) paint a picture of a technically sound, planned digital solutions to address the problem presented by substandard and falsified medicines, which appear to be growing internationally, particularly as purchases increasingly take...
Auteur principal: | Naughton, B |
---|---|
Format: | Record |
Publié: |
Pathways for Prosperity Commission
2018
|
Documents similaires
-
Trade in substandard and falsified medicines
par: Hagen, N, et autres
Publié: (2022) -
Substandard and Falsified Medicines in Myanmar
par: Mirai Sakuda, et autres
Publié: (2020-03-01) -
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
par: Hauk, C, et autres
Publié: (2021) -
How to achieve international action on falsified and substandard medicines.
par: Attaran, A, et autres
Publié: (2012) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
par: Elizabeth Pisani, et autres
Publié: (2021-08-01)